# Evaluation of Retinal and Vascular Features in Radiation Maculopathy After Intravitreal Injections of Ranibizumab

> **NCT04377295** · — · COMPLETED · sponsor: **Federico II University** · enrollment: 40 (actual)

## Conditions studied

- Radiation Maculopathy

## Interventions

- **DRUG:** Ranibizumab 0.5Mg/0.05Ml Oph Inj

## Key facts

- **NCT ID:** NCT04377295
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-30
- **Primary completion:** 2019-10-01
- **Final completion:** 2019-10-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04377295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04377295, "Evaluation of Retinal and Vascular Features in Radiation Maculopathy After Intravitreal Injections of Ranibizumab". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04377295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*